FDA Device recall Z-2205-2017
Herpes Simplex Virus I
- FDA Device
- Class II
- terminated
- Published 2017-06-07
On 2017-06-07 the FDA classified a Class II recall of Herpes Simplex Virus I by Cell Marque, citing cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as requi….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-2205-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-05-05 |
| Published | 2017-06-07 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Cell Marque |
| Distribution | US |
Product
Herpes Simplex Virus I; 7.0 mL Catalog number 361A-18. Microbiology - Analyte Specific Reagent In vitro diagnostic use - Analyte Specific Reagent
Reason
Cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as required by section 801 (e )(1) of the FD&C Act.
Identifiers
| code_info | 7.0 ml lot 1432301A, expiry 2017-10; lot 1525206A , expiry 201 8-08. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2205-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.